Acrivastine and pseudoephedrine and Bonjesta
Determining the interaction of Acrivastine and pseudoephedrine and Bonjesta and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acrivastine / pseudoephedrine
Brand name: Semprex-D
Synonyms: Acrivastine and Pseudoephedrine
Generic Name: doxylamine / pyridoxine
Brand name: Bonjesta, Diclegis
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acrivastine and pseudoephedrine-Bontril
- Acrivastine and pseudoephedrine-Bontril PDM
- Acrivastine and pseudoephedrine-Bontril Slow-Release
- Acrivastine and pseudoephedrine-Bontril Slow-Release Capsules
- Acrivastine and pseudoephedrine-Boostrix
- Acrivastine and pseudoephedrine-Boostrix Intramuscular
- Bonjesta-Actamin
- Bonjesta-Actamin Maximum Strength
- Bonjesta-Actemra
- Bonjesta-Actemra (Tocilizumab (Intravenous))
- Bonjesta-Actemra (Tocilizumab Auto-Injectors)
- Bonjesta-Actemra (Tocilizumab Prefilled Syringes)